关注
Elise Koch
Elise Koch
在 medisin.uio.no 的电子邮件经过验证
标题
引用次数
引用次数
年份
Interactome overlap between schizophrenia and cognition
E Koch, B Rosenthal, A Lundquist, CH Chen, K Kauppi
Schizophrenia Research 222, 167-174, 2020
172020
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals
E Koch, L Nyberg, A Lundquist, S Pudas, R Adolfsson, K Kauppi
Translational Psychiatry 11 (1), 520, 2021
132021
The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study
W Cheng, N Parker, N Karadag, E Koch, G Hindley, R Icick, A Shadrin, ...
The Lancet Psychiatry 10 (6), 441-451, 2023
92023
Drug repurposing candidates to treat core symptoms in autism spectrum disorder
E Koch, D Demontis
Frontiers in Pharmacology 13, 995439, 2022
72022
Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia
KS O'Connell, E Koch, HÇ Lenk, IA Akkouh, G Hindley, P Jaholkowski, ...
Psychiatry research 325, 115217, 2023
52023
Polygenic risk for schizophrenia has sex-specific effects on brain activity during memory processing in healthy individuals
E Koch, L Nyberg, A Lundquist, K Kauppi
Genes 13 (3), 412, 2022
32022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning
E Koch, K Johnell, K Kauppi
Pharmacoepidemiology and Drug Safety 32 (4), 446-454, 2023
22023
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging
A Supiyev, R Karlsson, Y Wang, E Koch, S Hägg, K Kauppi
Neurobiology of Aging 126, 103-112, 2023
12023
APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
S Håglin, E Koch, F Schäfer Hackenhaar, L Nyberg, K Kauppi
Scientific Reports 13 (1), 8433, 2023
12023
Candidates for drug repurposing to address the cognitive symptoms in schizophrenia
E Koch, K Kauppi, CH Chen
Progress in Neuro-Psychopharmacology and Biological Psychiatry 120, 110637, 2023
12023
400. Polygenic Architecture of Metabolic Markers Reveals Distinct Patterns of Overlap With Psychiatric Disorders
D van der Meer, Z Rahman, A Ottas, P Parekh, G Kutrolli, I Sønderby, ...
Biological Psychiatry 95 (10), S263-S264, 2024
2024
Shared genetic loci between clozapine metabolism and granulocyte counts
E Koch, N Parker, SK Lock, RL Smith, AA Shadrin, O Frei, AM Dale, ...
2024
Polygenic liability for antipsychotic dosage and polypharmacy-a real-world registry and biobank study
E Koch, A Kämpe, M Alver, S Sigurðarson, G Einarsson, J Partanen, ...
Neuropsychopharmacology, 1-7, 2024
2024
How real-world data can facilitate the development of precision medicine treatment in psychiatry
E Koch, AF Pardiñas, KS O’Connell, P Selvaggi, JC Collados, A Babic, ...
Biological Psychiatry, 2024
2024
NOVEL LOCI FOR ANTIDEPRESSANT RESPONSE IDENTIFIED FROM GENOME-WIDE ASSOCIATION STUDIES AND MULTI-TRAIT META-ANALYSES
E Koch, K Krebs, T Jürgenson, L Milani, K O'Connell, O Andreassen
European Neuropsychopharmacology 75, S53, 2023
2023
Novel genomic risk loci and improved prediction for treatment-resistant schizophrenia are revealed by leveraging polygenic overlap with body-mass index
K O'Connell, E Koch, H Lenk, I Akkouh, G Hindley, P Jaholkowski, ...
2022
APOE ɛ4, but not polygenic AD risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
S Håglin, E Koch, FS Hackenhaar, L Nyberg, K Kauppi
2022
The genetics of schizophrenia: sex, drugs, and cognition
E Koch
Umeå universitet, 2022
2022
Longitudinal effects of using and discontinuing CNS medications on cognitive functioning
E Koch, K Johnell, K Kauppi
bioRxiv, 2021.09. 13.460082, 2021
2021
O11. 4. INTERACTOME OVERLAP BETWEEN SCHIZOPHRENIA AND COGNITION
E Koch, B Rosenthale, A Lundquist, CH Chen, K Kauppi
Schizophrenia Bulletin 46 (Suppl 1), S28, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20